0001179110-12-011099.txt : 20120703 0001179110-12-011099.hdr.sgml : 20120703 20120703162352 ACCESSION NUMBER: 0001179110-12-011099 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120701 FILED AS OF DATE: 20120703 DATE AS OF CHANGE: 20120703 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SYNTA PHARMACEUTICALS CORP CENTRAL INDEX KEY: 0001157601 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 BUSINESS ADDRESS: STREET 1: 45 HARTWELL AVE CITY: LEXINGTON STATE: MA ZIP: 02421 BUSINESS PHONE: 781-274-8200 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: KUFE DONALD W CENTRAL INDEX KEY: 0001390646 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33277 FILM NUMBER: 12945374 MAIL ADDRESS: STREET 1: C/O ADHEREX TECHNOLOGIES INC. STREET 2: 4620 CREEKSTONE DRIVE, SUITE 200 CITY: DURHAM STATE: NC ZIP: 27703 4 1 edgar.xml FORM 4 - X0306 4 2012-07-01 0 0001157601 SYNTA PHARMACEUTICALS CORP SNTA 0001390646 KUFE DONALD W C/O SYNTA PHARMACEUTICALS CORP. 45 HARTWELL AVENUE LEXINGTON MA 02421 1 0 0 0 Common Stock 2012-07-01 4 A 0 7312 0 A 7312 D Director Stock Option (Right to Buy) 5.47 2012-07-01 4 A 0 10000 0 A 2022-07-01 Common Stock 10000 10000 D Represents a restricted stock grant subject to the Issuer's lapsing forfeiture right, which lapses as to 25% of the shares on each of September 30, 2012, December 31, 2012, March 31, 2013 and June 30, 2013, provided the Reporting Person continues to serve as director of the Issuer on such date. The option vests as to 25% of the shares on each of September 30, 2012, December 31, 2012, March 31, 2013 and June 30, 2013, provided the Reporting Person continues to serve as a director of the Issuer on such date. /s/ Ann Margaret Eames, Attorney-in-Fact 2012-07-03